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The ALS-associated protein FUS
assembles into a liquid-like compartment
to operate in vivo, but a risk of the
functionality conferred by the liquid
phase is aggregation to the disease-
linked solid phase. Aging diseases
caused by aggregation-prone proteins
may arise from a failure to maintain liquid-
phase homeostasis.
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Many proteins contain disordered regions of low-
sequence complexity, which cause aging-associ-
ated diseases because they are prone to aggregate.
Here, we study FUS, a prion-like protein containing
intrinsically disordered domains associated with
the neurodegenerative disease ALS. We show that,
in cells, FUS forms liquid compartments at sites of
DNA damage and in the cytoplasm upon stress. We
confirm this by reconstituting liquid FUS compart-
ments in vitro. Using an in vitro ‘‘aging’’ experiment,
we demonstrate that liquid droplets of FUS protein
convert with time from a liquid to an aggregated
state, and this conversion is accelerated by patient-
derived mutations. We conclude that the physiolog-
ical role of FUS requires forming dynamic liquid-like
compartments. We propose that liquid-like compart-
ments carry the trade-off between functionality and
risk of aggregation and that aberrant phase transi-
tions within liquid-like compartments lie at the heart
of ALS and, presumably, other age-related diseases.
INTRODUCTION
Cells have a problem: How do they organize their complex
biochemistry in time and space? Eukaryotic cells have ad-
dressed this problem by using functionally distinct compart-
ments, many of which are bound by membranes. In these cases,
it is easy to understand how the biochemistry is constrained in
one place: the membrane prevents the diffusion of molecules
in the absence of specific transport systems. However, many,
if not most, cellular compartments are not membrane enclosed
(Hyman and Brangwynne, 2011; Hyman et al., 2014; Li et al.,
2012; Weber and Brangwynne, 2012). Examples include germ
(P) granules (Brangwynne et al., 2009), processing (P/GW)1066 Cell 162, 1066–1077, August 27, 2015 ª2015 Elsevier Inc.bodies (Kedersha et al., 2005), stress granules (Wippich et al.,
2013), nucleoli (Brangwynne et al., 2011), Cajal bodies (Strze-
lecka et al., 2010) and likely signaling compartments (Banjade
and Rosen, 2014; Li et al., 2012). These structures are highly
dynamic, and the components within them are in constant
exchange with the surrounding cytoplasm or nucleoplasm.
Recently, an increasing number of these non-membrane-bound
compartments have been shown to behave like condensed
liquid phases of the cytoplasm or nucleoplasm (Aggarwal
et al., 2013; Brangwynne et al., 2009, 2011; Hubstenberger
et al., 2013; Lee et al., 2013; Wippich et al., 2013). It is thought
that these structures form by liquid-liquid demixing, often upon
a specific triggering event.
Domains of low-sequence complexity (LC domains) have
been implicated in the formation of membrane-less compart-
ments (Decker et al., 2007; Gilks et al., 2004; Han et al., 2012;
Kato et al., 2012; Malinovska et al., 2013; Toretsky and Wright,
2014). LC domains are also present in yeast prion proteins,
which have the ability to interconvert into fibers rather than a
liquid state (Alberti et al., 2009). Thus, proteins harboring these
domains have been called ‘‘prion-like.’’ Prion-like LC domains
are particularly abundant in RNA- and DNA-binding proteins
and have been conserved across evolution (Kim et al., 2013;
King et al., 2012; Malinovska et al., 2013). However, mutations
in prion-like proteins also cause devastating protein misfolding
diseases, and these diseases are typically accompanied by the
formation of solid aggregates (Gitler and Shorter, 2011; Kim
et al., 2013; Li et al., 2013; Ramaswami et al., 2013). Thus, deter-
mining how prion-like proteins organize cellular compartments
will not only advance our understanding of compartment forma-
tion but will also provide important insight into a diverse set of
aging-associated pathologies.
One prototypical prion-like protein involved in the compart-
mentalization of cells is the RNA-binding protein FUS. It is en-
riched in the nucleus and involved in transcription, DNA repair,
and RNA biogenesis (Polymenidou et al., 2012; Wang et al.,
2008, 2013). Mutations in FUS are associated with amyotrophic




B C Figure 1. FUS Forms Several Dynamic Com-
partments In Vivo
(A) Immunoblot of Kyoto HeLa cells without a
BAC transgene (WT) or with a BAC transgene for
expression of FUS-GFP (FUS-GFP). FUS-GFP cells
with FUS small interfering RNA (siRNA) treatment
(FUS siRNA). The expected molecular weight (MW)
of endogenous FUS is 75 kDa. The asterisk marks
transgenic FUS-GFP. The FUS-GFP expression
level (estimated by band intensity) is approximately
60% of the endogenous FUS. The total amount of
FUSexpressed in FUS-GFP cells (endogenous plus
FUS-GFP) is about 1.75-fold higher than the FUS
expression in wild-type cells. a-Tub, a-tubulin.
(B) Inverted black and white images of FUS-GFP-
expressing cells in control or actinomycin-D-
treated conditions (nuclear puncta are magnified
in the inset).
(C) Quantification of the average number of nu-
clear puncta in untreated (Untr.) and actinomycin-
D (ActD)-treated conditions (n = at least 10 per
condition). Error bars represent SD. *p < 0.00001.
(D) FUS-GFP-expressing cells in control, DNA-
damage, andheat-stress conditions. Sites of strong
FUS-GFP localization are shown by dark puncta at
the irradiation-induced DNA damage sites (marked
with red lines) and stress granules (marked with red
arrows). The insets show approximately 13-fold
magnifications of the FUS compartments.
(E) FUS-GFP fluorescence in the nucleus, cytoplasm, and stress granules (Granule) were measured after the induction of stress (time point 0) by time-lapse
imaging. The representative graph reports the fluorescence intensity in each compartment.
(F) FUS-GFP fluorescence in the nucleus, cytoplasm, and stress granules (Granule) weremeasured after the release of stress (time point 0) by time-lapse imaging.
(G) Recovery half-times (Characteristic time of recovery) of FUS-GFP fluorescence after photobleaching in the nuclear puncta, stress granules, and DNA
damage sites (n = 10 per condition). For nuclear puncta versus stress granule, p = 0.1016; for nuclear puncta versus DNA damage sites, p = 0.0004; for stress
granule versus DNA damage site, p = 0.0089. The line within the boxplot represents the median, and the outer edges of the box are the 25th and 75th percentiles.
The whiskers extend to the minimum and maximum values.
See also Movie S1.degeneration (FTLD) (Deng et al., 2014; Woulfe et al., 2010).
Recent reports show that the prion-like LC domains of FUS
can polymerize into fibrous amyloid-like assemblies in a cell-
free system (Han et al., 2012; Kato et al., 2012; Kwon et al.,
2013, 2014). Once assembled, these structures exhibit the
macroscopic behavior of hydrogels. However, it has been diffi-
cult to understand the relationship between amyloid-like hydro-
gels that form in vitro and the in vivo function of the protein,
because there has been little work on the dynamics of FUS in
living cells and the relationship between this dynamic behavior
and the onset of disease.
Here, we show that both in vivo and at physiological concen-
trations in vitro FUS forms liquid-like droplets. We further
demonstrate that the liquid-like state can convert into a solid
state and that this conversion is exacerbated by disease-associ-
ated mutations in the prion-like domain. Our findings suggest
that aberrant phase transitions may be at the heart of many
neurodegenerative diseases.
RESULTS
The Prion-like Protein FUS Assembles into Various
Dynamic Compartments In Vivo
Previous reports have implicated FUS in the formation of stress-
inducible compartments, such as DNA damage sites and stressgranules (Li et al., 2013; Mastrocola et al., 2013; Rulten et al.,
2014; Wang et al., 2013). These studies often used transient
transfection protocols and overexpression plasmids to study
the subcellular localization of FUS. We used an approach based
on BAC (bacterial artificial chromosome) transgeneOmics
(Poser et al., 2008). BACs have the advantage that they allow
the expression of transgenes from their native genomic environ-
ment, including most, if not all, regulatory elements. First, we
generated a BAC transgene for the expression of GFP-tagged
FUS and introduced it into HeLa and embryonic stem (ES) cells
to generate stable cell lines (Figure 1A). Next, we used mass
spectrometry to determine the physiological concentration of
FUS in HeLa cells (Figure S1A). We found that the concentration
is around 2 mM, with a technical precision between replicates of
2.24 ± 0.7 mM and an estimated accuracy of 2- to 3-fold
(Wisniewski et al., 2014). This makes FUS one of the top 5% of
proteins in terms of protein abundance. Because FUS is 2- to
4-fold enriched in the nucleus under normal conditions (Fig-
ure S1B), the local concentration in the nucleus may be between
4 and 8 mM.
Using FUS-GFP HeLa cells, we found that, in unstressed cells,
FUS predominately localized to the nucleus (Figure 1B), in agree-
ment with previous reports. We also noticed that FUS formed
small foci in the nucleoplasm (Figure 1B). A similar distribution
was observed in mouse ES cells (Figure S1C). Cells treatedCell 162, 1066–1077, August 27, 2015 ª2015 Elsevier Inc. 1067
with actinomycin D, a potent inhibitor of RNA polymerase II,
showed no nuclear assemblies (Figures 1B and 1C), confirming
previous observations that FUS is involved in transcription regu-
lation and splicing (Kwon et al., 2013; Schwartz et al., 2012; Yang
et al., 2014). This suggests that, under normal conditions, FUS
assembles into compartments that may be associated with tran-
scription or splicing.
FUS has also previously been implicated in DNA repair (Rulten
et al., 2014; Wang et al., 2013). Indeed, we found that FUS accu-
mulated at DNA lesions within a second of laser-mediated irradi-
ation (Figures 1D, S1C, and S1D; Movie S1). Next, we exposed
the FUS cell line to heat stress to induce previously reported
stress-associated compartments in the cytoplasm (Bosco
et al., 2010; Li et al., 2013). Indeed, FUS accumulated in the cyto-
plasm in heat-stressed cells and coalesced into stress granules
(Figures 1D and S1E; Movie S1). Formation and dissolution of
these stress granules was coupled to changes in cytoplasmic
and nuclear FUS levels (Figures 1E, 1F, and S1E;Movie S1), sug-
gesting that the coalescence of these compartments occurs over
a certain concentration of soluble components. To further inves-
tigate the dynamics of FUS protein in these compartments, we
photobleached FUS-containing cellular structures and followed
the recovery of the fluorescence over time. Indeed, for all three
structures examined, we observed a rapid exchange between
assembled and soluble FUS, with a half-time of recovery ranging
from hundreds of milliseconds to 1 s (Figures 1G and S1F).
Our data so far support previous work showing that FUS local-
izes to multiple different compartments, depending on the type
of stress the cell is experiencing. Our data further suggest that
these compartments are extremely dynamic. In the nucleus,
FUS localizes to active sites of transcription and rapidly assem-
bles on sites of DNA damage. Upon heat shock, FUS shuttles out
to the cytoplasm, where it forms a compartment in a concentra-
tion-dependent manner. In all these compartments, FUS turns
over within hundreds of milliseconds to around 1 s.
FUS Compartments Have Liquid Properties In Vivo
The dynamic nature of FUScompartments is reminiscent of other
RNA protein compartments such as P granules and nucleoli,
which form by liquid-liquid demixing in the cytoplasm or nucleo-
plasm. Three characteristics define a liquid-like compartment.
First, the components should undergo rapid internal rearrange-
ment. Second, the compartments should be roughly spherical
due to surface tension. Third, two droplets should fuse and relax
into one droplet. Therefore, we tested whether FUS compart-
ments have these liquid-like characteristics.
The constant mixing of components within a liquid can be
tested by a technique known as ‘‘half-bleach’’ (Brangwynne
et al., 2009; Hyman et al., 2014). In this method, roughly half a
structure is bleached, and then the distribution of the fluores-
cence within the photomanipulated structure is determined
over time (see Experimental Procedures for details). The spatio-
temporal analysis of such half-bleach events showed that
FUS was redistributed rapidly within stress granules and nuclear
FUS assemblies, from the unbleached area to the bleached area
(Figures 2A and 2B; Figure S2A; Movie S2). Thus, we conclude
that FUS molecules can diffuse freely in stress granules and nu-
clear assemblies, in agreement with a liquid material state.1068 Cell 162, 1066–1077, August 27, 2015 ª2015 Elsevier Inc.To investigate the shape of stress-induced FUS structures, we
observed FUS-GFP-expressing cells with a digital scanned light-
sheet microscope (DSLM) with structured illumination, which al-
lows improved 3D imaging of dynamic subcellular objects (Gao
et al., 2014). Using this imaging technology, we found that FUS
granules are spherical (Figure 2C). The calculated sphericity
was close to that of a perfect sphere for both heat-induced
and arsenate-induced cytoplasmic FUS granules (Figure 2D).
We cannot measure the sphericity of the nuclear structures
because they are too small. We then used DSLM microscopy
to perform a time-resolved analysis of individual FUS granules
in the cytoplasm. We found that FUS granules underwent
frequent fusion events and, as soon as they interacted, rapidly
relaxed into a spherical shape (Figures 2E and S2B; Movie S2).
The relaxation time of these granules was on the order of a few
minutes (Figure 2F). Using the relaxation time and the FRAP
(fluorescence recovery after photobleaching) times, we approx-
imated viscosity values, as previously described (Brangwynne
et al., 2009). We estimate viscosities around 10- to 100-fold of
water (10–100 mPa,s). We were unable to see fusion events
for nuclear FUS compartments, presumably because they are
fixed in place on the DNA.
Therefore, FUS assemblies have all the hallmarks of a liquid
state: they turn over quickly; are spherical; and when they fuse,
they relax into one spherical assembly (Hyman et al., 2014).
Taken together, these experiments show that FUS assemblies
are liquid droplets, which probably form by liquid-liquid demixing
in the cytoplasm or nucleoplasm.
Recombinant FUS Phase Separates into Dynamic Liquid
Droplets In Vitro
Our data so far indicate that FUS is a component of liquid-like
compartments in vivo that form by demixing from the cytoplasm.
To investigate whether FUS is able to phase separate on its own,
we studied the behavior of recombinant GFP-tagged FUS ex-
pressed in insect cells (see Experimental Procedures for details)
(Figures 3A and 3B; Figures S3A and S3B). For these experi-
ments, we chose a FUS-GFP concentration of 10 mM, which is
slightly higher than the measured physiological concentration
(Figure S1A) but easier toworkwith in our imaging-based assays.
At this concentration,we found that FUSwasdiffusely distributed
(Figure 3C). At a concentration of 500 mM, about 100-fold higher
than the physiological concentration, FUS formed a gel-like state
(Figure 3C; Movie S3), as previously reported (Kato et al., 2012).
Because of the discrepancy with our in vivo data, which shows
that FUS coalesces into liquid compartments in living cells, we
looked for conditions that promote FUS assembly into compart-
ments at physiological concentrations. A 10% solution of either
dextran or polyethylene glycol (PEG) induced assembly of FUS
into round micrometer-sized structures (Figures 3C and S3C–
S3G). To characterize whether these FUS assemblies have
liquid-like properties, we performed a series of biophysical ex-
periments. First, we investigated whether FUS molecules can
freely move around within the droplets. Indeed, the FUS signal
rapidly rearranged from the unbleached region to the bleached
region of a half-bleached droplet (Figures 3D–3F and S3H;Movie
S4), consistent with a high internal mobility. The ability of a




B Figure 2. FUS Compartments Have Liquid-
like Properties In Vivo
(A) Representative heatmap kymograph showing
fluorescence intensity within one half-bleached
FUS-GFP stress granule over time. AU, arbitrary
units.
(B) Internal rearrangement of fluorescent FUS-
GFP molecules within a half-bleached FUS-GFP
stress granule in (A) is shown by quantification of
fluorescence in bleached (orange line) versus un-
bleached regions (blue lines) over time. Intensity
changes in a bleached or an unbleached pixel re-
gion over time was plotted.
(C) Raw and rendered 3D shapes of a stress
granule in heat- or arsenate-stressed living cell.
The panels show the xy, xz, and yz planes,
respectively.
(D) A plot showing the sphericity values of heat-
or arsenate-induced stress granules (n = 10 per
condition). A value of 1 represents a sphere. Error
bars represent SD. p = 0.5445.
(E) Raw and rendered montages of FUS-GFP
stress granule fusion events in heat- and arsenate-
induced stress conditions.
(F) The shape changes of an FUS-GFP droplet over
the time course of a fusion event measured as
aspect ratio (ratio between the long axis and the
short axis of a stress granule over time with an
exponential fit). As fused granules relax to a
spherical shape, the aspect ratio reaches 1.
See also Movie S2.liquids from solid gels (Hyman et al., 2014). Therefore, we next
asked whether FUS droplets are deformable by shear force.
Indeed, under such conditions, FUS droplets changed their
shape, as would be expected for a dynamic liquid with no mem-
ory of its previous state (Figure 3G; Movie S4). Furthermore, we
found that when two FUS droplets touched each other, they
rapidly fused and relaxed into one larger droplet within seconds
(Figures 3H and S3I; Movie S4). Such rapid relaxation times are
expected for liquid droplets with low viscosity.
Previous studies had identified the N-terminal prion-like
domain as critical for the formation of hydrogels (Kato et al.,
2012). Therefore, we generated a deletion mutant of FUS lacking
this N-terminal domain (FUSDLC) and purified it from insect cells
using the same protocol as for wild-type FUS. When we mixed
10 mM of wild-type or FUSDLC protein with 10% dextran, only
wild-type protein formed droplets, whereas truncated FUS re-
mained diffuse (Figure S3J). This indicates that the prion-like
domain is essential for forming liquid droplets, presumably
because of its sticky nature and ability to undergo many weak
interactions.Cell 162, 1066–1077,Therefore, FUS structures have all the
hallmarks of liquid droplets both in vivo
and in vitro: they are spheres, they fuse,
they deform under shear stress, and
they rearrange their contents within sec-
onds. This indicates that under physiolog-
ical conditions, FUS does not assemble
into solid-like aggregates or gels butrather forms dynamic droplets that exhibit all the properties of
a true liquid. It further confirms that FUS has an intrinsic ability
to phase separate and form liquid droplets, suggesting that
FUS may play a central role in forming liquid compartments at
sites of DNA damage and during stress.
Multivalent PAR Chains Nucleate FUS Droplets In Vivo
and In Vitro
Previous studies identified a poly(ADP) ribose (PAR)-binding
domain in the C-terminal region of FUS and showed that FUS
is rapidly recruited to DNA damage sites in a PAR-dependent
manner (Mastrocola et al., 2013). Indeed, we found that PAR
polymerase 1 (PARP1) arrives within seconds of DNA damage,
and FUS was detectable immediately after arrival of PARP1 (Fig-
ure 4A). To investigate whether PAR is required for FUS accumu-
lation, we interfered with PAR formation by adding an inhibitor of
PARP1/2 to cells shortly before laser-mediated irradiation (Rul-
ten et al., 2014). Indeed, inhibition of PARP1/2 prevented the
recruitment of FUS (Figures 4B and 4C). Conversely, inhibition







B Figure 3. Reconstituted FUSCompartments
Have Liquid-like Properties
(A) Recombinant human FUSwas tagged with GFP
at the C terminus, separated by a 13-amino-acid
linker. The protein was purified from insect cells,
and the His tag was cleaved off using Prescission
Protease.
(B) Coomassie-stained SDS-PAGE gel of purified
FUS-GFP (82 kDa). MW, molecular weight.
(C) Purified FUS-GFP investigated by fluorescence
microscopy. Diffuse: 10 mMFUS-GFP. Gel: 500 mM
FUS-GFP. Droplet: 10 mM FUS-GFP in the pres-
ence of a molecular crowder (10% dextran). Also
see corresponding Movie S3 for FUS-GFP gel.
(D) Recovery of fluorescence intensity of an in-
vitro-formed FUS-GFP droplet after half-bleach.
The site of bleach is marked by a red arrow.
(E) Representative heatmap kymograph showing
fluorescence intensity within a half-bleached
in vitro FUS-GFP droplet over time shown in (D).
AU, arbitrary units.
(F) Internal rearrangement of fluorescent FUS-GFP
molecules within a half-bleached FUS-GFP droplet
in (D and E) is shown by the quantification of the
fluorescence intensity in the bleached (blue line)
and unbleached (green line) regions of the droplet.
Intensity changes in a bleached or an unbleached
pixel region over time was plotted. Please note that
the continuous upward slope of both the bleached
and unbleached region is due to exchange of
molecules from solution.
(G) Montage of an FUS-GFP droplet deforming
under shear flow.
(H) Montage of two FUS-GFP droplets fusing under
shear flow.
See also Movies S3 and S4.FUS at DNA lesions (Figures 4B and 4D). This suggests that PAR
polymers are required for the recruitment as well as the pro-
longed presence of FUS in DNA damage-associated compart-
ments. To study whether PAR affects FUS droplet formation
in vitro, we first adjusted the FUS concentration in our cell-free
assay to 0.4 mM and lowered the concentration of dextran. At
this concentration, we observed no spontaneously formed FUS
droplets. However, when purified PAR was added, FUS droplet
formation was strongly enhanced (Figures S4A–S4C). In sum-
mary, these data provide evidence for the intrinsic ability ofmulti-
valent PAR chains to nucleate the formation of FUS droplets.
Therefore, we conclude that local PAR synthesis and the coop-
erative PAR-binding activity of FUS are required to drive the for-
mation of a non-membrane-bound compartment for DNA repair.
Droplets Formed from Mutant FUS Have Different
Biophysical Properties
FUS can form pathological protein aggregates, and specific mu-
tations in FUS have been identified in patients suffering from1070 Cell 162, 1066–1077, August 27, 2015 ª2015 Elsevier Inc.neurodegenerative diseases (Deng et al.,
2014). Previous studies have shown that
a patient-derived mutation in the prion-
like domain of FUS (G156E) has anincreased tendency to form aggregates (Nomura et al., 2014).
To investigate the link between the compartment-forming abili-
ties of FUS and disease, we expressed G156E FUS-GFP in in-
sect cells and purified the protein using the same protocol as
used previously for wild-type FUS (Figures 5A and 5B). When
10 mM wild-type FUS and G156E FUS were incubated in
500 mM salt, only diffuse fluorescence was seen over many
hours (Figure S5A). Upon dilution of G156E FUS to a concentra-
tion of 10 mM in the presence of dextran, we found that it formed
liquid-like structures, similar to those observed for wild-type
FUS. We were also unable to observe any obvious differences
in the properties of G156E and wild-type droplets (data not
shown). In addition, we expressed G156E FUS-GFP from a
BAC transgene in HeLa cells, but we could not detect any
obvious differences in FUS compartments formed in wild-type
cells (data not shown).
Next, we set up an ‘‘aging’’ experiment in which we added
dextran to FUS solutions and monitored the behavior of the
droplets with time. Using an optical tweezer, we first showed
AC D
B Figure 4. Poly(ADP) Ribose Formation
Nucleates FUS Compartments In Vitro and
In Vivo
(A) HeLa cells expressing FUS-mCherry and
PARP1-GFP are imaged after DNA damage
induction by laser micro-irradiation. Normalized
fluorescence intensity of FUS-mCherry (green) or
PARP1-GFP (blue) at DNA damage sites is plotted
over time after DNA damage induction.
(B) FUS-GFP-expressing cells at 1 min and 45 min
after DNA damage induction by laser micro-
irradiation in control, PARP1-, or PARG-inhibitor
(inhib.)-treated conditions. Sites of laser micro-
irradiation are shown by red lines. Dark puncta are
sites of strong FUS-GFP concentration.
(C) Representative graph showing the FUS-GFP
fluorescence (fluoresc.) intensity in control (green)
and PARP-inhibitor (orange) conditions over time
after DNA damage induction.
(D) Percentage of cells with FUS-GFP at damage
sites in 1 or 45 min after DNA damage in control
and PARG-inhibitor-treated conditions (n = 10 per
condition). Error bars represent SD. The p value at
1 min = 0.5185; the p value at 45 min = 0.0011.that one FUS droplet held by one laser beam can fuse with
several other droplets (Movie S5). To quantify this behavior, we
used two laser beams to control fusion events (Figure 5C; Movie
S6). The results of a typical experiment are shown in Figure 5D.
Between 0 and 2 hr after droplet formation, wild-type FUS drop-
lets fused very quickly, often within hundreds of milliseconds
(Movie S6). Similar behavior was seen for G156E FUS. However,
the relaxation time of G156E FUS was significantly longer than
for wild-type FUS (Figure 5E), and the spread of values became
much broader, with some droplets taking as long as 15 s to fuse.
More strikingly, as the droplets aged in a test tube, we noticed
that an increasing fraction of the G156E FUS droplets no longer
fused (Figure 5F; Movie S6) so that, after 8 hr, we could detect no
fusion events for G156E FUS, while 81% of the wild-type FUS
droplets still fused. By 12 hr, wild-type droplets also stopped
fusing. This indicates that there is indeed a change in the bio-
physical properties of FUS droplets with time. It further suggests
that the properties of theG156E FUSdroplets are changingmore
quickly than those of the wild-type FUS droplets. This is consis-
tent with the observation that G156E has a higher propensity to
aggregate as observed by Nomura et al. (2014). Concomitant
with the decline in fusion ability, we also noticed fibrous struc-
tures arising in the G156E FUS droplets (Figure S5B; Movie
S7). Therefore, we conclude that FUS droplets age and undergo
drastic changes in their biophysical properties and morphology.
Patient-DerivedMutations Promote aConversion of FUS
from a Droplet to a Fiber State
Next, we investigated the aging morphology of FUS droplets by
fluorescencemicroscopy. Figure 6A shows a typical experiment.
For wild-type FUS, the droplets increased in size with time
so that, by 8 hr, large droplets were observed in all fields. For
G156E FUS, the droplets also increased in size. However, by
8 hr, hardly any G156E droplets remained. Rather, only fibrous
structures could be seen (Figure 6A). For wild-type FUS, mainly
droplets were seen by 8 hr, although some fibers were nowdetectable as well. By 12 hr, most of the wild-type FUS protein
had converted into fibers, but a few droplets could still be
observed. Next, we investigated another patient-derived mutant
of FUSwith amutation adjacent to the prion-like domain (R244C)
and found that R244C also accelerated the conversion of FUS
droplets to a fibrous state (Figure S6A).
Therefore, we can conclude that, with time, a solution of FUS
containing liquid droplets will convert into fibrous structures.
Although wild-type and mutant FUS convert from droplets to
fibers, the mutant consistently converts more quickly than the
wild-type.Whenwe lookedmore carefully at the time points con-
taining aggregates, we saw that some of the droplets had short
fibers (Figure 6A), while others hadmuch longer fibers emanating
from them. We call these structures with small fibers ‘‘sea
urchins,’’ because they are reminiscent of similarly named tran-
sition structures seen in crystallization studies (Vekilov, 2004),
and longer fibers ‘‘starbursts’’ (Figure 6B; Movie S7). Time-lapse
imaging of the sea urchins revealed that the fibers protruding
from the surface continuously grew until the structure resembled
that of a commonly observed starburst (Movie S7). One
intriguing possibility is that this structure is the transition struc-
ture of a droplet converting into fibers. Such a process is consis-
tent with the droplets acting as centers of fiber nucleation and
growth.
To quantify the biophysical properties of the FUS fibers, we
performed photobleaching experiments on structures from
wild-type and G156E FUS. At t (time) = 0, both wild-type and
G156E droplets recovered quickly after photobleaching (Fig-
ure 6C). However, by t = 8 hr, the G156E structures no longer
recovered, suggesting that they interconverted from a liquid
to an aggregated state. Even within one fibrous structure, the
fibers projecting out turned over more slowly than the body (Fig-
ure S6B). This shows that, over time, a population of FUS protein
converts from a liquid to a solid state. We confirmed this by
performing cryoelectron microscopy (cryo-EM) studies of the





Figure 5. The Physical Properties of FUS Droplets Change with Time and Are Accelerated by a Patient-Derived Mutation in the Prion-like
Domain
(A) Recombinant human FUS with a single ALS-associated mutation (G156E, +) in the prion-like domain was expressed and purified from insect cells.
(B) Coomassie-stained SDS-PAGE gel of purified G156E FUS-GFP (82 kDa). MW, molecular weight.
(C) Diagram illustrating the method to control in vitro fusion experiments using two optical traps demonstrated by the signal of two FUS droplets. The green bar
indicates the time of a fusion event, which can be inferred from the increase in the combined normalized laser signal. AU, arbitrary units.
(D) Representative montages of ‘‘fusion’’ and ‘‘no-fusion’’ events in the optical trap experiments.
(E) A boxplot of fusion times of wild-type (WT) and G156E FUS-GFP droplet pairs scaled by the mean drop size at different time points using optical trap. The line
within the boxplot represents the median and the outer edges of the box are the 25th and 75th percentiles. The whiskers extend to the most extreme points not
considered outliers. Outliers are calculated as the points that are smaller than q1  1:5ðq3  q1Þ and larger than q3  1:5ðq3 +q1Þ, where q1 and q3 are the 25th
percentile and 75th percentile, respectively. N/A indicates that fusion times could not be determined because fusion events were no longer detectable.
s, seconds; h, hour.
(F) Fraction of wild-type (WT) and G156E FUS-GFP droplet pairs showing fusion at different time points in vitro using an optical trap. Error bars represent binomial
confidence intervals. h, hours.
See also Movie S6.amorphous and lacked ordered structures (Figure S6C). The
fiber state of FUS, instead, was characterized by many fibrillar
assemblies with a diameter of around 9 nm, and many of these
fibrils were laterally aligned (Figure S6C). These structures are
reminiscent of the amyloid-like aggregates identified in previous
work (Kato et al., 2012). Thus, we conclude that the liquid droplet
state is metastable and transitions into a thermodynamically
more stable aggregated state with time.
Many ALS-associated mutations map to the C-terminal nu-
clear localization sequence (NLS) of FUS. Mutations in the NLS
increase the cytosolic fraction of FUS (Kwiatkowski et al.,
2009; Vance et al., 2009). We confirmed this result by making
a BAC cell line containing a deletion of the NLS (Figure S6D).
Because phase transitions are extremely sensitive to protein
concentration, we hypothesized that these NLS mutations could
accelerate the conversion of FUS to a fibrous state by increasing
the concentration of FUS in the cytoplasm. Indeed, we found that
increasing concentrations of FUS had a higher propensity to1072 Cell 162, 1066–1077, August 27, 2015 ª2015 Elsevier Inc.convert from a droplet to a fibrous state (Figures S6E and
S6F). Therefore, we conclude that the aggregation of FUS is
concentration dependent and that ALS-associated mutations
in FUS may promote the formation of aggregates as seen in pa-
tient cells by accelerating the conversion from a liquid droplet to
a fibrous state.
DISCUSSION
In this paper, we show that, both in vivo and at physiological pro-
tein concentrations in vitro, the prion-like protein FUS forms
liquid compartments. The evidence for this is 3-fold. First, the in-
dividual FUS molecules rapidly rearrange within the compart-
ment. Second, the compartments formed by FUS are spherical.
Finally, two FUS compartments can fuse and relax into one
sphere. FUS rapidly shuttles between liquid compartments in
the nucleus and the cytoplasm depending on the type of stress.
Importantly, we show that, with time, a population of FUS
AB C
Figure 6. FUS Converts from a Liquid Droplet to Fibrous Aggregates
(A) Representative images of the morphological changes in in vitro droplets of
wild-type (WT) or G156E FUS-GFP during an ‘‘aging’’ experiment over 8 hr.
(B) 3D rendered morphology of a G156E FUS-GFP ‘‘starburst.’’
(C) Recovery of fluorescence after photobleaching of wild-type (WT) FUS-GFP
or G156E FUS-GFP assemblies at time points 0 and 8 hr (h). Error bars
represent SD over seven independent measurements.
See also Movie S7.droplets converts from a liquid state to an aggregated state,
which is reminiscent of the pathological state seen in ALS pa-
tients with mutations in the FUS protein. This conversion from
liquid to solid is accelerated either by mutations in the prion-
like domain that induce the early onset of ALS or by raising the
protein concentration, which mimics mutations in the NLS.
Therefore, our data suggest that aberrant phase transitions
may be at the heart of ALS and potentially other related diseases.
FUS compartments are amember of an expanding set of RNA-
protein compartments, such as P granules and nucleoli, which
probably form by liquid-liquid demixing from cytoplasm. Demix-
ing, or phase separation, is a powerful way to locally and rapidly
form compartments when needed. Indeed, FUS moves to sites
of DNAdamagewithin seconds of a triggering event, presumably
forming a compartment that recruits myriad additional factors
required for DNA damage repair (Dutertre et al., 2014; Lukaset al., 2011). The liquid-like nature of the compartment means
that DNA repair enzymes could diffuse rapidly within the
compartment, while the phase boundary would maintain a high
local concentration of these enzymes and provides identity to
the compartment (Hyman and Brangwynne, 2011; Hyman
et al., 2014; Weber and Brangwynne, 2012).
Solid aggregates of FUS protein are commonly seen in ALS
patients. However, our results clearly show that, under physio-
logical conditions, FUS forms a liquid. Therefore, the onset of
ALS must involve, in some way, a transformation from a liquid
to an aggregated state. One explanation for this transformation
is that the raised concentration of FUS in liquid compartments
triggers aggregation. In fact, many experiments in vivo and
in vitro have shown that increasing the concentration of FUS
converts the protein into an aggregated state (Shelkovnikova
et al., 2014; Sun et al., 2011). This is presumably the mechanism
underlying patient mutations in the NLS of FUS, which also leads
to an increased cytoplasmic concentration (Kwiatkowski et al.,
2009; Vance et al., 2009). Indeed, we have shown that, in vitro,
the conversion from liquid to a solid-like state is concentration
dependent (Figure S6F). The liquid-to-solid phase transition
that we observe in vitro is reminiscent of the process of protein
crystallization, where formation of a metastable liquid phase
often precedes the formation of crystals. Although the chemistry
and physics of protein crystallization is not fully understood, it is
thought that the higher density of proteins in the liquid phase
triggers nucleation of the crystal (Dumetz et al., 2008; Galkin
and Vekilov, 2000; Lomakin et al., 2003; Vekilov, 2010). An alter-
native idea is that the orientation and the altered dynamics of
the molecules at the phase boundary promote crystal formation
(Vekilov, 2004).
The droplets with fibers protruding from them are remarkably
similar to the transition states in protein crystallization studies.
For instance, when lysozyme or hemoglobin is crystalized, inter-
mediate liquid droplets can be seen with small fibers emanating
from them (Galkin et al., 2002; Galkin and Vekilov, 2000; Vekilov,
2004). These states are also reminiscent of previously reported
states that precede the formation of amyloid in in vitro aggrega-
tion reactions of the yeast prion Sup35 (Serio et al., 2000). An
alternative idea would be that there are two competing reactions
in a test tube: liquid compartment formation and fibrous
aggregation. Compartment formation is much quicker, but the
soluble protein could slowly aggregate in the background, thus
depleting the pool of monomeric FUS and leading to disas-
sembly of the FUS droplets over time. We think this idea is less
compelling, because we observe a decrease in droplet fusion
with time, a change in droplet morphology, and also the droplets
increase in size during incubation (compare panels 0 hr and 4 hr
in Figure 6A). However, most likely, both conversion of liquid
droplets into fibers structures and a fibrous aggregation reaction
in the solution are taking place at the same time.
One problem is that we still do not know how pathological
aggregates arise in living cells. Do they form in liquid compart-
ments, or do they form in the bulk cytoplasm or nucleoplasm?
We speculate that the liquid-solid transformation of FUS initially
takes place in subcellular compartments but that later stages of
the disease are characterized by aggregation reactions occur-
ring in a compartment-independent manner. This is becauseCell 162, 1066–1077, August 27, 2015 ª2015 Elsevier Inc. 1073
Figure 7. Diagram Illustrating the Molecular Mechanisms Underly-
ing the Formation of FUS Compartments and Their Conversion into
an Aggregated State
Left: FUS compartment formation upon DNA damage is driven by PAR poly-
merase and local PAR formation. PAR polymerase and other proteins (X)
are modified with PAR chains in the process. PAR formation leads to FUS
recruitment and initiates phase separation and compartment formation
through LC domain interactions. Other proteins, such as EWS and TAF15 are
likely recruited, thus forming a compartment for DNA damage repair. Right:
FUS compartments form through phase separation from a concentrated so-
lution of FUS, a reaction probably driven by weak interactions between prion-
like LC domains. Liquid FUS droplets convert with time into an aggregated
state, which presumably is associated with disease. LC domains are indicated
in red; RB, RNA- and PAR-binding domains, indicated in blue.amyloid-like aggregates are highly infectious, and once they
have formed, they can seed further aggregation reactions in
the same or in neighboring cells (Jucker and Walker, 2013).
We were surprised to see that two distinct point mutations
induced such a strong effect in vitro, whereas the disease would
only manifest in a living organism after many years. However,
in vivo, there will be many factors that are working against
aberrant conformations, such as molecular chaperones and
ATP-consuming degradation machines. As these control mech-
anisms weaken with age (Taylor and Dillin, 2011), there presum-
ably is a decline in the ability of a cell to counteract the formation
of aberrant conformational states in compartment-forming
proteins. Indeed, in vitro, we see both the wild-type and mutant
FUS droplets changing biophysical properties, although the
mutant changes more quickly than the wild-type protein. There-
fore, it may be difficult to recapitulate the mutant state of the
protein in living cells, because disease formation is a gradual
process and young cells have very active quality control machin-
ery in place. Indeed, our preliminary results suggest that when
G156E FUS is expressed from its own promoter in HeLa cells,
it has similar dynamics as wild-type FUS. Future work in differen-1074 Cell 162, 1066–1077, August 27, 2015 ª2015 Elsevier Inc.tiated neuronal systems will be required to identify the specific
mechanisms that fail on a pathway to disease.
Recent work has shown that at high concentrations, the prion-
like LC domain of FUS forms amyloid-like fibers and that this
leads tohydrogel formation in a test tube (Kato et al., 2012). These
experiments were operating at 100 times the physiological
cellular concentration and, therefore, are unlikely to represent
the physiological state of the protein, which we think is a liquid
state. However, it seems likely that these amyloid structures are
similar or identical to the fibrous aggregates that we see in our
in vitro agingexperiments. Therefore, taken together,wecanpro-
pose the following model as to how FUS enters into a disease
state (Figure7): normally, FUS forms liquidcompartments in cells.
During transcription, FUS assembles into liquid compartments at
active genes; during DNA damage, FUS assembles into liquid
compartments at sites of DNA damage; under stress conditions,
FUS rapidly shuttles to the cytoplasm and forms stress granules.
The liquid nature of these compartments allows rapid diffusion
necessary for chemical reactions on biological timescales. How-
ever, liquid formation comes with a cost: high local concentra-
tions of a conformationally promiscuous protein. As cells age
and the activity of the quality control machinery declines, and
exacerbated bymutations that increase the aggregation propen-
sities, FUS will convert into an aggregated state. Therefore, if a
cell uses a dynamic liquid state to perform a physiological func-
tion, it will have to fight its whole life against the thermodynamic
drive toward aggregate formation and disease.
We would like to reiterate that we do not think that fibrous
aggregates represent the physiological function of FUS. Rather,
the physiological function of the FUS protein is to act as a liquid,
probably with little fixed structure. However, we currently have
no information as to themolecular mechanism that drives the for-
mation of a liquid-like state, apart from the fact that it requires the
prion-like LC domain (Figure 7). The prion-like domain of FUS is
intrinsically disordered, and the liquid state of FUS probably
arises from its ability to sample many conformational states.
Anything that increases the strength of interaction between
prion-like domains could lead to formation of aggregates rather
than liquids. Indeed, a mutant that we selected, G156E, maps to
the prion-like domain and has been shown in vitro to exacerbate
the aggregation potential of the protein (Nomura et al., 2014).
This will presumably involve a number of conformational states,
starting off with an increase in viscosity of the liquid and ending
in the commonly seen aging-associated aggregates. Our EM
data show that, in vitro, the liquid-like droplets are amorphous,
without any obvious structure. Therefore, liquid formation itself
does not require formation of obvious oligomers or fibers. How-
ever, it is possible, in vivo, that small oligomers are constantly
forming and being disassembled by the quality control machin-
ery. Future studies using cryo-EM will be required to investigate
the structure of FUS compartments in vivo.
Our data do not address the issue of why aggregates are asso-
ciated with disease. There are two possibilities: the aggregates
themselves are toxic, or the proteins themselves, by being
locked in a less dynamic state, are no longer able to perform their
physiological function. In the case of FUS, this function is to
help protect cells against stress, both in the nucleus and
the cytoplasm. However, the intermediate biophysical states
discussed earlier could make cells more prone to stress,
because the decrease in dynamics may impair the formation of
stress compartments or the shuttling between the nucleus and
the cytoplasm. It is possible that chemicals that slightly increase
the fluidity of compartments could help ameliorate the develop-
ment of the disease.
EXPERIMENTAL PROCEDURES
Detailed methods are available in the Supplemental Experimental Procedures.
Generation of Cell Lines
Stable HeLa cell lines expressing human FUS were generated using BAC
recombineering technology (Poser et al., 2008).
DNA Damage Laser Cutting Assay
DNA damage was induced by applying 25 UV pulses at 12 equidistant
dots along a 6-mm line within the nucleus using a laser micro-irradiation setup
previously described (Behrndt et al., 2012; Mayer et al., 2010).
Stress and Inhibitor Treatment of HeLa Cells
The temperature increase from 37C to 42C, 1 mM sodium arsenate, or 720
Osm DMEM was used to induce heat, arsenate, or osmotic stress, respec-
tively. The stress granules were imaged using a fast DSLM microscope with
structured illumination (Planchon et al., 2011). We used 20 mg/ml of PARP
inhibitor Abt-888 (Santa Cruz Biotechnology), 300 mM of PARG inhibitor
Gallotannin (Santa Cruz Biotechnology), and 2.5 mg/ml of the transcription
inhibitor actinomycin D (Sigma-Aldrich).
FUS Protein Purification from Insect Cells
Recombinant versions of FUS-GFPwere purified using the baculovirus expres-
sion system (Hoell et al., 2011; Schwartz et al., 2012). Cells were lysed in resus-
pension buffer (50 mM Tris-HCl, 1 M KCl, 5% glycerol, 0.1% CHAPS, 1 mM
DTT, pH 7.4), and FUS-GFP was captured using nickel-nitrilotriacetic acid
(Ni-NTA) resin (QIAGEN) and eluted with elution buffer (resuspension buffer +
250mM imidazole). His andMBP tagswere cleavedoff using ahistidine-tagged
Prescission Protease (in house) during dialysis against FUS dialysis buffer
(50 mM Tris-HCl, 1 M KCl, 5% glycerol, 1 mM DTT, pH 7.4). Furthermore,
size exclusion chromatography was performed with a Superdex 200 Increase
10/300 GL column (GE Healthcare Life Sciences) using an Akta Ettan fast pro-
tein liquid chromatography (FPLC) system (GE Healthcare Life Sciences).
Hydrogel Formation
MBP-FUS-GFP was concentrated to 500 mM (50 mg/ml) in FUS dialysis
buffer and dialyzed against FUS gelation buffer (20 mM Tris-HCl, 200 mM
KCl, 0.5 mM EDTA, 1 mM DTT, pH 7.5) at 4C for 48 hr to induce gelation
(Kato et al., 2012).
In Vitro FUS Assays
FUS-GFP at indicated concentrations was incubated with 10% dextran (T500,
Pharmacosmos) in 50 mM Tris-HCl, 500 mM KCl, 2.5% glycerol and 1 mM
DTT, pH 7.4, for 10 min. To induce ‘‘aging,’’ the assay was subjected to
12 rpm on a bench top rotator at room temperature.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and seven movies and can be found with this article online at
http://dx.doi.org/10.1016/j.cell.2015.07.047.
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